Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program

被引：10

作者：

Stewart, A. ^{[1
]}

Roberts, J. A. ^{[2
,3
]}

Wallis, S. C. ^{[3
]}

Allworth, A. M. ^{[1
]}

Legg, A. ^{[2
]}

McCarthy, K. L. ^{[1
,3
]}

机构：

[1] Royal Brisbane & Womens Hosp, Infect Dis Unit, Brisbane, Qld, Australia

[2] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia

[3] Univ Queensland, Fac Med, UQ Ctr Clin Res, Brisbane, Qld, Australia

来源：

关键词：

D O I：

10.1016/j.ijantimicag.2018.02.008

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：941 / 942

页数：2

共 5 条

[1]

Brisbane, 2017, BRISB QUEENSL APR 20

Jones, Bruce M. ;

Smith, Bradley ;

Bland, Christopher M. .

Liscio, Jordan L. ;

Mahoney, Monica V. ;

Hirsch, Elizabeth B. .

[4]

Terracciano J, 2017, CURR THER RES CLIN E, V84, P22, DOI 10.1016/j.curtheres.2017.03.002

Xiao, Alan J. ;

Miller, Benjamin W. ;

Huntington, Jennifer A. ;

Nicolau, David P. .